Joseph M Hayes

13PUBLICATIONS
18CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsGlycoconjugatesBiologically active moleculesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Sep 25, 2025
Computationally Motivated Discovery of Biogenic Compounds with Potent CDK9 Inhibition and In Vitro Effects against Glioblastoma.

Zahra R Khan, Philip J Welsby, Izabela Stasik

|Apr 08, 2025
Structure-Based Discovery Targeting GSK-3α Reveals Potent Nanomolar Selective 4-Phenyl-1<i>H</i>-benzofuro[3,2-<i>b</i>]pyrazolo[4,3-<i>e</i>]pyridine Inhibitor with Promising Glioblastoma and CNS-Active Potential in Cellular Models.

Thomas D Emmerich, Eleanor J Taylor-Chilton, Elena Caballero

|Oct 21, 2024
Evidence for the Quercetin Binding Site of Glycogen Phosphorylase as a Target for Liver-Isoform-Selective Inhibitors against Glioblastoma: Investigation of Flavanols Epigallocatechin Gallate and Epigallocatechin.

Serafeim Alexopoulos, Megan McGawley, Roshini Mathews

|May 11, 2024
Synthesis, In Silico and Kinetics Evaluation of <i>N</i>-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and <i>N</i>-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors.

Levente Homolya, Rachel T Mathomes, Luca Varga

|Apr 30, 2024
Discovery of Potent Multikinase Type-II Inhibitors Targeting CDK5 in the DFG-out Inactive State with Promising Potential against Glioblastoma.

Zahra R Khan, Philip J Welsby, Izabela Stasik

|May 27, 2023
<i>In Silico</i>-Motivated Discovery of Novel Potent Glycogen Synthase-3 Inhibitors: 1-(Alkyl/arylamino)-3H-naphtho[1,2,3-de]quinoline-2,7-dione Identified as a Scaffold for Kinase Inhibitor Development.

Thomas D Emmerich, Joseph M Hayes

Pageof 3

Frequent Collaborators

4 joint publications

László Somsák

2 joint publications

Ana Martinez

1 joint publications

Anna-Maria G Psarra

1 joint publications

Subrayal M Reddy